Chinese Patients With BCR::ABL1-Negative Myeloproliferative Neoplasms: Immunophenotype of Myeloid Monocytes

被引:0
|
作者
Liang, Fengting [1 ]
Zou, Yangyang [1 ]
Huang, Liangmei [1 ]
Pang, Dongxiao [1 ]
JinbaoPang, Xuelan
Liang, Xuelan [2 ]
机构
[1] Bobai Cty Peoples Hosp, Yulin, Peoples R China
[2] Shanxi Med Univ, Hosp 2, Taiyuan, Peoples R China
关键词
immunophenotypic analysis; monocytes; myeloproliferative syndromes;
D O I
10.1111/ijlh.14461
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionThe main terms for typical BCR::ABL1-negative myeloproliferative neoplasms (MPNs) are essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF). Monocytes in MPN patients are involved in their inflammation and form an important part of the pathophysiology of MPN patients.MethodsWe used flow cytometry to study the immunophenotype of bone marrow monocytes from MPN patients (N = 118) and to correlate it with clinical parameters (including genetics, pathology, blood counts, personal information).ResultsThe results showed that bone marrow monocyte cells from MPN patients expressed the inflammation-related marker CD16 at higher levels than healthy controls. Second, bone marrow monocytes from Overt-PMF patients expressed CD11b at higher levels than monocytes from ET patients. Finally, certain specific monocyte subpopulations in MPN patients correlated with their clinical parameters. For example, in patients with ET and PMF, CD64+ monocytes were positively correlated with WBC and LDH. In PMF patients, the proportion of bone marrow monocytes was positively correlated with the grade of myelofibrosis, and CD15+ monocytes positively correlated with WBC and IPSS scores.ConclusionOur results provide insights into the immune microenvironment of MPNs based on immunophenotypic features and provide potential immune markers for MPNs occurrence and development.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Immunophenotype of myeloid granulocytes in Chinese patients with BCR::ABL1-negative myeloproliferative neoplasms
    Liang, Fengting
    Liang, Xuelan
    Pan, Lingang
    Jin, Qianni
    Deng, Ju
    Hong, Minglin
    Wei, Wei
    Hao, Zhuanghui
    Ren, Huanying
    Wang, Hongwei
    Chen, Xiuhua
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [2] GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms
    Yang, Naery
    Park, Sholhui
    Cho, Min-Sun
    Lee, Miae
    Hong, Ki-Sook
    Mun, Yeung Chul
    Seong, Chu-Myong
    Huh, Hee Jin
    Huh, Jungwon
    ANNALS OF LABORATORY MEDICINE, 2018, 38 (04) : 296 - +
  • [3] Genomic alterations in blast phase of BCR::ABL1-negative myeloproliferative neoplasms
    Chen, Dong
    Weinberg, Olga K.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 (06) : 839 - 844
  • [4] SETBP1 OVEREXPRESSION IN CLASSICAL BCR/ABL1-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
    Albano, F.
    Anelli, L.
    Zagaria, A.
    Coccaro, N.
    Tota, G.
    Ricco, A.
    Casieri, P.
    Minervini, A.
    Impera, L.
    Minervini, C. Francesco
    Specchia, G.
    HAEMATOLOGICA, 2013, 98 : 110 - 111
  • [5] BCR::ABL1-negative myeloproliferative neoplasms in the era of next-generation sequencing
    Mroczkowska-Bekarciak, Aleksandra
    Wrobel, Tomasz
    FRONTIERS IN GENETICS, 2023, 14
  • [6] DARS expression in BCR/ABL1-negative myeloproliferative neoplasms and its association with the immune microenvironment
    Xiong, Hao
    Liao, Minjing
    Zhang, Huitao
    Li, Yanhong
    Bai, Jun
    Zhang, Jinping
    Li, Lijuan
    Zhang, Liansheng
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [7] The Clinical Significance of Circulating Microparticles Concerning Thrombosis in BCR/ABL1-negative Myeloproliferative Neoplasms
    Aswad, Mohamed Hussam
    Kissova, Jarmila
    Ovesna, Petra
    Rihova, Lucie
    Penka, Miroslav
    IN VIVO, 2021, 35 (06): : 3345 - 3353
  • [8] Diagnosis- and Prognosis-Related Gene Alterations in BCR::ABL1-Negative Myeloproliferative Neoplasms
    Morishita, Soji
    Komatsu, Norio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [9] BCR-ABL negative myeloproliferative neoplasms
    Metzgeroth, G.
    Lengfelder, E.
    Griesshammer, M.
    Reiter, A.
    ONKOLOGE, 2012, 18 (12): : 1130 - +
  • [10] Infections and vaccination in patients with BCR::ABL1 negative myeloproliferative neoplasms
    Haberbosch, S. M.
    Mertin, F.
    Hochhaus, A.
    Heidel, F.
    Hilgendorf, I
    Crodel, C. C.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 108 - 108